Read More Pharma Industry News FDA inspection at Zydus Lifesciences’ Moraiya facility results in four Form 483 observations US FDA issues four Form 483 observations at Zydus Lifesciences’ Moraiya plant; company commits to corrective action while confirming no data integrity concerns. bySrinathAugust 7, 2022